Management of DM with GLP-1 Agonists

Dear Dr. Renukaprasad A R, Long-acting GLP-1 receptor agonists are effective in controlling glycemia a little better than short-acting agents. These agonists, however, have some dose-dependent adverse effects. Therefore, an analysis of evidence-based clinical data regarding the benefits and adverse effects of GLP-1 receptor agonists can help guide physicians involved in delivering care to DM patients. Join Dr. Supratik Bhattacharyya, an expert endocrinologist, in an exclusive MasterSeries session on "GLP-1 Agonists in DM management: Comparative Analysis" on 23rd November 2022, 3:00 PM IST onwards. Click to Know More   Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*